The Trump administration will be scaling back its oversight of Obamacare starting next year, moving some duties to the states, amid criticism from advocates that it will hurt patients.
This week, the administration quietly informed insurers that it would give states more power to decide which plans are sold on Obamacare's marketplaces in 2018. The move comes the same week Trump said he might try to withhold subsidies to Obamacare insurers to get Democrats on board with repealing the law.
The change affects Obamacare plans sold on healthcare.gov, used by residents in 38 states to purchase Obamacare. It does not affect the 12 state-run exchanges.
The Centers for Medicare and Medicaid Services currently reviews all of the plans and their rates before they are sold on the exchanges. CMS also reviews which drugs those plans will cover. Some states, however, recommend which plans the government should sell on the exchanges.
Starting in 2018, CMS will rely on those recommendations instead of performing its own reviews. Technically, CMS still has to give the final say on which plans can be sold on the exchanges.
Get the Exclusive
05.04.2024